by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersLexia LLC

All Warning Letters

Lexia LLC

Warning LetterOpen

367 Riverside Drive, Suite 100 Franklin , TN 37064-8977 United StatesFEI 3011863647Issued Apr 7, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3011863647.

Violations7

Issue DateApr 7, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: Lexia LLC
Location: 367 Riverside Drive, Suite 100 Franklin , TN 37064-8977 United States
FEI Number: 3011863647
Country: United States
Issue Date: April 07, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Lexia LLC FDA Warning Letter, April 7, 2026